References
- Sanodiya BS, Thakur GS, Baghel RK, Prasad GB, Bisen PS. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol 2009; 10:717–742.
- Mizuno T, Wang G, Zhang J, Kawagishi H, Nishitoba T, Li J. Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects. Food Rev Int 1995; 11:151–166.
- Zhang HN, Lin ZB. Hypoglycemic effect of Ganoderma lucidum polysaccharides. Acta Pharmacol Sin 2004; 25:191–195.
- Yuen JW, Gohel MD. Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer 2005; 53:11–17.
- Brodsky RA, Jones RJ. Aplastic anemia. Lancet. 2005; 365:1647–1656.
- Kojima S. Aplastic anemia in the Orient. Int J Hematol 2002; 76:173–174.
- Aoki K, Ohtani M, Shimizu H. Epidemiological approach to the etiology of aplastic anemia. Aplastic anemia. In: Hibino S, Takaku F, Shahrdi NT, eds. Baltimore: University Park; 1978:155–170.
- Pyatt DW, Yang Y, Mehos B, Le A, Stillman W, Irons RD. Hematotoxicity of the chinese herbal medicine Tripterygium wilfordii Hook F in CD34-positive human bone marrow cells. Mol Pharmacol 2000; 57:512–518.
- Kyeon HM, Song WT, In KH, Kim JS. A case of reversible hypoplastic pancytopenia due to Ganoderma japonicum. Korean J Hematol 1991; 26:129–133.